biOasis Technologies Ord Shs BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

GREY:BIOAF - Post by User

biOasis Technologies Ord Shs > 2-million-dollar fee

<< Previous

Bullboard Posts

Next >>

Comment by MBT123on Jan 19, 2023 9:51pm

148 Views

Post# 35234711

RE:RE:RE:2-million-dollar fee

Not sure what your smoking tonight but the market has decided this thing is worth a whopping $2.5 for everything absolutely everything!! Call your buddies up I'm sure you could raise enough too buy it for cash...Hire JBroke as the CEO as he knows so much and has so many connections outside of the park...and watch this blast off to the moon or whatever you loved saying! It's done .10 is a dream..I said years ago she ran her last company to zero and she did it again! Only myself to blame for sticking around this train wreck! Just hope people didn't loose life savings that would sting..

<< Previous

Bullboard Posts

Next >>

The top 5 mining dividend stocks in Canada